Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 42, Issue 5, 2015, Pages 771-780

  Thackeray, James T ^a   Bankstahl, Jens P ^a   Wang, Yong ^a   Wollert, Kai C ^a   Bengel, Frank M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Inflammation; Myocardial infarction; PET; Small animal imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEPARIN; ISOFLURANE; KETAMINE; XYLAZINE; ANESTHETIC AGENT; ANTICOAGULANT AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CARDIAC IMAGING; CONSCIOUS SEDATION; CORONARY ARTERY OCCLUSION; DIET RESTRICTION; DRUG MEGADOSE; EVALUATION STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART INFARCTION; HEART MUSCLE CELL; INHALATION ANESTHESIA; LOW DRUG DOSE; MALE; MYOCARDITIS; NONHUMAN; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; TAIL VEIN; WAKEFULNESS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; INFLAMMATION; METABOLISM; MOUSE; REPERFUSION INJURY; SCINTISCANNING;

ANESTHETICS, GENERAL; ANIMALS; ANTICOAGULANTS; FASTING; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEPARIN; INFLAMMATION; ISOFLURANE; KETAMINE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; XYLAZINE;

EID: 84925483229     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2956-7     Document Type: Article

References (21)

1. Anzai T. Post-infarction inflammation and left ventricular remodeling: a double-edged sword. Circ J 2013;77:580–7.
2. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538–43. doi:10.1093/eurheartj/ehi180.
3. Moon H, Park HE, Kang J, Lee H, Cheong C, Lim YT, et al. Noninvasive assessment of myocardial inflammation by cardiovascular magnetic resonance in a rat model of experimental autoimmune myocarditis. Circulation 2012;125:2603–12. doi:10.1161/CIRCULATIONAHA.111.075283.
4. Schatka I, Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med 2014;55:99–106. doi:10.2967/jnumed.112.115121.
5. Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F, et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 2012;59:153–63. doi:10.1016/j.jacc.2011.08.066.
6. Cheng VY, Slomka PJ, Ahlen M, Thomson LE, Waxman AD, Berman DS. Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: a randomized controlled trial. J Nucl Cardiol 2010;17:286–91. doi:10.1007/s12350-009-9179-5.
7. Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50:563–8. doi:10.2967/jnumed.108.055616.
8. Minamimoto R, Morooka M, Kubota K, Ito K, Masuda-Miyata Y, Mitsumoto T, et al. Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings. J Nucl Cardiol 2011;18:516–20. doi:10.1007/s12350-011-9358-z.
9. Lee KH, Ko BH, Paik JY, Jung KH, Choe YS, Choi Y, et al. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice. J Nucl Med 2005;46:1531–6.
10. Flores JE, McFarland LM, Vanderbilt A, Ogasawara AK, Williams SP. The effects of anesthetic agent and carrier gas on blood glucose and tissue uptake in mice undergoing dynamic FDG-PET imaging: sevoflurane and isoflurane compared in air and in oxygen. Mol Imaging Biol 2008;10:192–200. doi:10.1007/s11307-008-0137-4.
11. Thackeray JT, Bankstahl JP, Wang Y, Korf-Klingebiel M, Walte A, Wittneben A, et al. Targeting post-infarct inflammation by PET imaging: comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model. Eur J Nucl Med Mol Imaging 2014. doi:10.1007/s00259-014-2884-6.
12. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 2011;17:581–8. doi:10.1038/nm.2354.
13. Thorn SL, deKemp RA, Dumouchel T, Klein R, Renaud JM, Wells RG, et al. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model. J Nucl Med 2013;54:1637–44. doi:10.2967/jnumed.112.110114.
14. Hildebrandt IJ, Su H, Weber WA. Anesthesia and other considerations for in vivo imaging of small animals. ILAR J 2008;49:17–26.
15. Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, et al. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 2006;47:999–1006.
16. Kreissl MC, Stout DB, Wong KP, Wu HM, Caglayan E, Ladno W, et al. Influence of dietary state and insulin on myocardial, skeletal muscle and brain [F]-fluorodeoxyglucose kinetics in mice. EJNMMI Res 2011;1:8. doi:10.1186/2191-219X-1-8.
17. Wu HM, Sui G, Lee CC, Prins ML, Ladno W, Lin HD, et al. In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device. J Nucl Med 2007;48:837–45. doi:10.2967/jnumed.106.038182.
18. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest 1985;76:1819–27. doi:10.1172/JCI112174.
19. Constantinides C, Mean R, Janssen BJ. Effects of isoflurane anesthesia on the cardiovascular function of the C57BL/6 mouse. ILAR J 2011;52:e21–31.
20. Toyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, et al. Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET. Nucl Med Biol 2004;31:251–6. doi:10.1016/S0969-8051(03)00124-0.
21. Wollenweber T, Roentgen P, Schäfer A, Schatka I, Zwadlo C, Brunkhorst T, et al. Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging. Circ Cardiovasc Imaging 2014;7:811–8. doi:10.1161/CIRCIMAGING.114.001689.